Growing community of inventors

Creteil, France

Michael Rivard

Average Co-Inventor Count = 5.37

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Michael RivardThierry Martens (6 patents)Michael RivardPatrick Couvreur (4 patents)Michael RivardAngelo Paci (4 patents)Michael RivardDidier Desmaele (3 patents)Michael RivardJoachim Caron (3 patents)Michael RivardRoberta Foresti (2 patents)Michael RivardRoberto Motterlini (2 patents)Michael RivardCharles Skarbek (1 patent)Michael RivardDidier Desmael (1 patent)Michael RivardAnthony Ollivier (1 patent)Michael RivardMichael Rivard (6 patents)Thierry MartensThierry Martens (7 patents)Patrick CouvreurPatrick Couvreur (25 patents)Angelo PaciAngelo Paci (4 patents)Didier DesmaeleDidier Desmaele (9 patents)Joachim CaronJoachim Caron (3 patents)Roberta ForestiRoberta Foresti (2 patents)Roberto MotterliniRoberto Motterlini (2 patents)Charles SkarbekCharles Skarbek (1 patent)Didier DesmaelDidier Desmael (1 patent)Anthony OllivierAnthony Ollivier (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Institut Gustave Roussy (4 from 95 patents)

2. Centre National De La Recherche Scientifique (2 from 5,072 patents)

3. Institut National De La Sante Et De La Recherche Medicale (2 from 1,743 patents)

4. Université Paris Est Creteil Val De Marne (2 from 33 patents)


6 patents:

1. 10519179 - Highly efficient NRF2 activators-co-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation

2. 10125157 - Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation

3. 10098901 - Derivatives of oxazaphosphorines and therapeutic uses thereof

4. 9944669 - Fumarate-CO-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation

5. 9428530 - Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation

6. 9073957 - Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/14/2025
Loading…